There is a great need for sensitive, precise, and easily accessible analytical detection techniques for protein sequencing.

Biologics Quality Control: The Growing Need for Accessible Proteomics

The emergence of mRNA vaccines and cell and gene therapies has pushed innovation in analytical methods.

Emerging Therapies Drive Analytical Advancements

Effective analytics will eliminate failures, deviations, and non-conformances.

 Analyzing Exabytes

Topic

Articles

Protagen Protein Services, a CRO, now offers quicker and more accurate characterization of biomolecular stability using differential scanning calorimetry (DSC).

Protagen Protein Services Expands Analytical Services for Biosimilar Development

The TSQ Fortis Triple Quadrupole Mass Spectrometer from Thermo Fisher Scientific offers fast, robust liquid chromatography-mass spectrometry (LC-MS/MS) analysis for clinical research laboratories.

Enhanced Analysis with New Triple Quadrupole Mass Spectrometer

The Lumis electron backscatter diffraction (EBSD) detector incorporates a large-format complementary metal oxide semiconductor (CMOS) sensor to enable higher sample throughput, higher resolution measurements, and precise phase identification.

New EBSD Detector Features Advanced Sensors and Optics

The company’s new electron microscopy and microanalysis solutions offer scientists enhanced research capabilities.

Innovations from Thermo Fisher Scientific Advance Electron Microscopy and Microanalysis

An expansion of laboratory facilities in Geneva, Switzerland expands SGS services for high-order structure analysis.

SGS Increases Biopharma Characterization Capabilities

Researchers from the Department of Chemistry and Warwick Medical School developed a way to synthesize polymers to accelerate antimicrobial activity screening.

University of Warwick Develops New Method for Screening Polymeric Antimicrobials

Adeline Siew is editor for Pharmaceutical Technology Europe. She is also science editor for Pharmaceutical Technology.

Materials in contact with a drug must be fully characterized to ensure they do not negatively affect the safety and efficacy of the product.

E&L Risk Assessment for Biologic Drug Products

Edward Godek is manager of process and technical operations at Glatt Air Techniques, NJ, info.gat@glatt.com.

Chris O’Callaghan is senior product manager at Innopharma Technology, Dublin, Ireland, ocallaghanc@innopharmalabs.com.

Ian Jones, PhD, is founder and CEO of Innopharma Technology and Innopharma College of Applied Sciences, Dublin

Piyush Patel, is formulation technologies manager at Colorcon, PA, ppatel@colorcon.com.

A process control system based on PAT can compensate for variations in particle size, resulting in more consistent coating thickness in a Wurster coating process.

Exploring a Modern Control Strategy for Wurster Coating

Susan Haigney is lead editor of Pharmaceutical Technology and Pharmaceutical Technology Europe.

Industry experts discuss the challenges of performing glycan analysis and how companies can gain specific expertise from outsourcing partners.

Outsourcing Glycan Analysis

The acquisition will increase Metrohm’s spectroscopy offerings and capabilities.

Analytics

Biologics Quality Control: The Growing Need for Accessible Proteomics

Emerging Therapies Drive Analytical Advancements

Analyzing Exabytes